The global sleep apnea devices market is set to expand at a steady CAGR of 9.5%, growing from USD 8.2 billion in 2023 to USD ...

According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US ...

You can do better than sleeping pills or counting sheep. From free apps and wearable trackers to smart mattresses and climate-control solutions, rest better with the best sleep tech we've tested.

KeyBanc Capital Markets adjusted its price target on Inspire Medical Systems (NYSE:INSP) shares, lowering it to $234 from $236, while maintaining an Overweight rating on the stock. The revision ...

Sleepiness at the wheel is a significant contributing factor to motor vehicle accidents. A new analysis published in ...

Medicare covers sleep tests for certain conditions such as sleep apnea, narcolepsy, or parasomnia, but limitations may apply.

Piper Sandler reaffirmed its positive stance on Inspire Medical Systems (NYSE:NYSE:INSP), maintaining an Overweight rating with a $260.00 price target. The endorsement comes after a steep 14.15% ...

The global sleep apnea implants market is expected to grow from USD 317.1 million in 2023 to USD 1,158.1 million by 2033, at ...

A wearable medical device that tests for the breathing disorder obstructive sleep apnoea has been recommended for use in the NHS by the National Institute for Health and Care Excellence (NICE).

The RayNeo X3 Pro Smart Glasses mark the arrival of the true AR era. With built-in computing power, the model eliminates the need for external devices, delivering enhanced performance in a compact, ...

Sleep Apnea Device Market Insights: Growing awareness of sleep disorders and health risks drive demand for sleep apnea diagnostics and therapies. US, NY, UNITED STATES, January 15, 2025 ...